The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EGFR amplification predicted selective sensitivity to PARP inhibitors with high PARP-DNA trapping potential in human GBM.
 
W. K. Alfred Yung
Stock and Other Ownership Interests - DNATrix
Honoraria - Amgen; DNAtrix
Consulting or Advisory Role - Boehringer Ingelheim; DNAtrix
Patents, Royalties, Other Intellectual Property - DNATrix
 
Shaofang Wu
No Relationships to Disclose
 
Feng Gao
No Relationships to Disclose
 
Siyuan Zheng
No Relationships to Disclose
 
Jie Ding
No Relationships to Disclose
 
Chen Zhang
No Relationships to Disclose
 
Xialong Li
No Relationships to Disclose
 
Ravesanker Ezhilarasan
No Relationships to Disclose
 
Ningping Feng
No Relationships to Disclose
 
John Frederick De Groot
Employment - Helsinn Therapeutics (I); ZIOPHARM Oncology (I)
Leadership - ZIOPHARM Oncology (I)
Stock and Other Ownership Interests - Gilead Sciences; ZIOPHARM Oncology (I)
Consulting or Advisory Role - Abbvie; Agios; AstraZeneca; Blue Earth Diagnostics; Boston Biomedical; CarThera; Deciphera; Five Prime Therapeutics; Foundation Medicine; Genentech/Roche; GenomiCare; GW Pharmaceuticals; Insys Therapeutics; Kadmon; Kairos Ventures; KIYATEC; Merck; Mundipharma Research; Novogen; Vascular Biogenics
Research Funding - Deciphera; EMD Serono; Lilly; Mundipharma; Novartis; Sanofi
Patents, Royalties, Other Intellectual Property - AstraZeneca - Research Support; Deciphera Pharmaceuticals - Research Support; Eli Lilly - Research Support; EMD-Serono - Research Support; Novartis - Research Support; Sanofi-Aventis - Research Support
Travel, Accommodations, Expenses - Blue Earth Diagnostics
 
Erik P. Sulman
Honoraria - BrainLAB; Merck Sharp & Dohme; Novocure; PER
Consulting or Advisory Role - Abbvie; Blue Earth Diagnostics; Merck Sharp & Dohme; Novocure
Research Funding - Abbvie (Inst); Novocure (Inst)
Travel, Accommodations, Expenses - BrainLAB; Merck Sharp & Dohme; Novocure; PER
 
Timothy Heffernan
Stock and Other Ownership Interests - Cullgen
Consulting or Advisory Role - Cullgen
Research Funding - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - M D Anderson cancer center
 
Dimpy Koul
No Relationships to Disclose